Concepedia

Lisa H. Morrissey

LH

18

Publications

1.8K

Citations

14

H-Index

1999

Active since

Affiliations

Tennessee Oncology(Current)

Sarah Cannon

University of South Carolina Upstate

Lisa H. Morrissey is an author at Tennessee Oncology specializing in cancer therapeutics, cancer research, and oncology.

Top concepts

Publications per year

1999–2005

18

Publications

18

Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin’s Lymphoma

John D. Hainsworth, Sharlene Litchy, Howard A. Burris et al. · Journal of Clinical Oncology · 2002 · 417 citations

Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma

John D. Hainsworth, Howard A. Burris, Lisa H. Morrissey et al. · Blood · 2000 · 263 citations

Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma

John D. Hainsworth, Howard A. Burris, Lisa H. Morrissey et al. · Blood · 2000 · 248 citations

Paclitaxel and Gemcitabine Chemotherapy for Advanced Transitional-Cell Carcinoma of the Urothelial Tract: A Phase II Trial of the Minnie Pearl Cancer Research Network

Anthony A. Meluch, F. Anthony Greco, Howard A. Burris et al. · Journal of Clinical Oncology · 2001 · 210 citations

Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma

John D. Hainsworth, Howard A. Burris, Sharlene Litchy et al. · Cancer · 2000 · 140 citations

Rows per page

1–5 of 18